Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.49 |
| ▸ | PPARG | P37231 | 3/20 | 0.49 |
| ▸ | PPARD | Q03181 | 3/20 | 0.49 |
| ▸ | PPARA | Q07869 | 3/20 | 0.49 |
| ▸ | TOP1 | P11387 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | BLM | P54132 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | FABP4 | P15090 | 2/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.49 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2053235 | 0.88 | AKR1B1 (0.37) | PTPN1PPARGPPARDPPARAHSD17B10 | |
| SCHEMBL11159042 | 0.76 | TERT (0.50) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL11162359 | 0.76 | TERT (0.50) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL11159043 | 0.76 | TERT (0.50) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL3447981 | 0.76 | TERT (0.53) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL8456883 | 0.75 | TERT (0.45) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL8456891 | 0.75 | TERT (0.45) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL9518086 | 0.73 | CES2 (0.38) | — | |
| Bicarbonate SCHEMBL10592426 | 0.73 | TERT (0.75) | TERTPTPN1PPARGPPARDPPARA | |
| Bicarbonate SCHEMBL3789802 | 0.73 | TERT (0.75) | TERTPTPN1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2687205-B1 | FENTANYL TRANSDERMAL PATCH | ICURE PHARMACEUTICAL CORP (KR) | 2020-12-23 | — | — | EP | claimed |
| US-20190091168-A1 | FORMULATION FOR ENHANCED TRANSDERMAL ABSORPTION OF DRUG | UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) | 2019-03-28 | — | — | US | claimed |
| US-9295655-B2 | Fentanyl transdermal patch | ICURE (KR) | 2016-03-29 | — | — | US | claimed |
| EP-2687205-A2 | FENTANYL TRANSDERMAL PATCH | Icure Pharmaceutical Corp. (KR) | 2014-01-22 | — | — | EP | claimed |
| US-20140005617-A1 | FENTANYL TRANSDERMAL PATCH | ICURE (KR) | 2014-01-02 | — | — | US | claimed |
| US-20130165875-A1 | TRANSDERMAL ABSORPTION PREPARATION | ICURE PHARMACEUTICAL INC. (KR) | 2013-06-27 | — | — | US | claimed |
| EP-2561865-A2 | TRANSDERMAL ABSORPTION PREPARATION | Icure Pharmaceutical Inc. (KR) | 2013-02-27 | — | — | EP | claimed |
| CN-102946873-A | Percutaneous absorption preparation | ICURE PHARM INC | 2013-02-27 | — | — | CN | claimed |
| CN-113166024-A | Aromatic compounds and their medical use | 巴斯夫股份公司 | 2021-07-23 | — | — | CN | disclosed |
| EP-2687205-B1 | FENTANYL TRANSDERMAL PATCH | ICURE PHARMACEUTICAL CORP (KR) | 2020-12-23 | — | — | EP | disclosed |
| US-20190091168-A1 | FORMULATION FOR ENHANCED TRANSDERMAL ABSORPTION OF DRUG | UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) | 2019-03-28 | — | — | US | disclosed |
| US-9295655-B2 | Fentanyl transdermal patch | ICURE (KR) | 2016-03-29 | — | — | US | disclosed |
| CN-102946873-B | percutaneous absorption preparation | ICURE PHARM INC | 2015-05-13 | — | — | CN | disclosed |
| EP-2687205-A2 | FENTANYL TRANSDERMAL PATCH | Icure Pharmaceutical Corp. (KR) | 2014-01-22 | — | — | EP | disclosed |
| US-20140005617-A1 | FENTANYL TRANSDERMAL PATCH | ICURE (KR) | 2014-01-02 | — | — | US | disclosed |
| US-20130165875-A1 | TRANSDERMAL ABSORPTION PREPARATION | ICURE PHARMACEUTICAL INC. (KR) | 2013-06-27 | — | — | US | disclosed |
| EP-2561865-A2 | TRANSDERMAL ABSORPTION PREPARATION | Icure Pharmaceutical Inc. (KR) | 2013-02-27 | — | — | EP | disclosed |
| CN-102946873-A | Percutaneous absorption preparation | ICURE PHARM INC | 2013-02-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190091168-A1 | FORMULATION FOR ENHANCED TRANSDERMAL ABSORPTION OF DRUG | APP, PSEN2, PSEN1 | TERT 912/4885PTPN1 4072/4885PPARG 128/4885 |
| US-20140005617-A1 | FENTANYL TRANSDERMAL PATCH | CD69, OPRD1, OPRL1 | TERT 2255/4885PTPN1 4839/4885PPARG 2815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.